US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.82

+0.27001.10%

Post-market: 25.000.1800+0.73%16:35 EDT

Volume:12.52K

Turnover:308.51K

Market Cap:55.72M

PE:- -

High:25.15

Open:24.50

Low:24.35

Close:24.55

52wk High:27.02

52wk Low:15.63

Shares:2.24M

Float Shares:2.24M

Volume Ratio:0.27

T/O Rate:0.56%

Dividend:1.70

Dividend Rate:6.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alkermes Schedules Second-quarter Results Call and Webcast

Alkermes to Report Second Quarter Financial Results on July 28, 2026

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS

Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), NovoCure (NVCR) and Bristol-Myers Squibb (BMY)

Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4

Alkermes Price Target Announced at $60.00/share by JP Morgan

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS

Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose

THOMSON REUTERS

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis

THOMSON REUTERS

Bank of America Securities Remains a Sell on Alkermes (ALKS)

Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60

THOMSON REUTERS

Noronex plans substantial multi-instrument equity raising

Sabre Resources Secures $2m to Accelerate Drilling in Tennant Creek Copper-Gold Belt

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)

Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts

Mizuho Securities Remains a Buy on Relmada Therapeutics (RLMD)

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PSIL/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.82,"timestamp":1788379200000,"preClose":24.55,"halted":0,"volume":12522,"hourTrading":{"tag":"盘后","latestPrice":25,"preClose":24.82,"latestTime":"16:35 EDT","volume":18,"amount":446.41998,"timestamp":1788381359320,"change":0.18,"changeRate":0.007252,"amplitude":0.012893},"delay":0,"changeRate":0.010997963340122182,"floatShares":2244976,"shares":2244976,"eps":0,"marketStatus":"Post-Mkt","change":0.27,"latestTime":"09-02 17:01:35 EDT","open":24.5,"high":25.145,"low":24.3501,"amount":308505.45315,"amplitude":0.032379,"askPrice":26.26,"askSize":12,"bidPrice":24.68,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":24.55,"sharesOutstanding":1184976,"nav":24.77,"aum":55609064.46,"dividendRate":0.068638,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":24.8,"preClose":24.55,"latestTime":"08:30 EDT","volume":22,"amount":539.989956,"timestamp":1788352229605,"change":0.25,"changeRate":0.010183,"amplitude":0.013035},"postHourTrading":{"tag":"盘后","latestPrice":25,"preClose":24.82,"latestTime":"16:35 EDT","volume":18,"amount":446.41998,"timestamp":1788381359320,"change":0.18,"changeRate":0.007252,"amplitude":0.012893},"volumeRatio":0.274974,"impliedVol":0.4809,"impliedVolPercentile":0.8651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2244976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.274974,"shares":2244976,"dividePrice":1.7036,"high":25.145,"amplitude":0.032379,"preClose":24.55,"low":24.3501,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.82,"committee":-0.846154,"eps":0,"divideRate":0.068638,"volume":12522,"delay":0,"ttmEps":0,"open":24.5,"prevYearClose":17.17,"prevWeekClose":25.2464,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":26.33,"twentyDayClose":24.66,"sixtyDayClose":19.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651948609","title":"Alkermes Schedules Second-quarter Results Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2651948609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651948609?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:00","pubTimestamp":1784059224,"startTime":"0","endTime":"0","summary":"Alkermes schedules second-quarter results call and webcastAlkermes schedules a conference call and webcast at 8 a.m. ET on July 28, 2026 to discuss second-quarter financial results.Webcast player and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL4ZHnfJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","PSCH","IBRN","ALKS","MEDX","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651248620","title":"Alkermes to Report Second Quarter Financial Results on July 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651248620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651248620?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:00","pubTimestamp":1784059200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA9LS4JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","PSCH","MEDX","IBRN","ALKS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143954","title":"Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143954?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:10","pubTimestamp":1783959019,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU2324357040.USD","LU0889565916.HKD","LU0029874061.USD","BK4137","BK4588","BK4139","BK4082","MEDX","LABU","ALKS","FBT","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585","PRAX","LU0320765992.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","IE0002141913.USD","HCSG","BK4581","PSCH","IE00BJJMRZ35.SGD","XBI","XLV","PSIL","TMDX","IE00BJT1NW94.SGD","IBRN","LU0109394709.USD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128211","title":"Alkermes Plc : TD Cowen Raises Target Price to $57 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651128211?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:29","pubTimestamp":1783949398,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","PSIL","ALKS","MEDX","IBRN","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651811463","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), NovoCure (NVCR) and Bristol-Myers Squibb (BMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651811463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651811463?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:00","pubTimestamp":1783947641,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on COMPASS Pathways (CMPS), NovoCure (NVCR) and Brist...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-compass-pathways-cmps-novocure-nvcr-and-bristol-myers-squibb-bmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-compass-pathways-cmps-novocure-nvcr-and-bristol-myers-squibb-bmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0061475181.USD","IE00B2B36J28.USD","LU1670711123.USD","LU2125154935.USD","BK4581","LU1670710588.SGD","LU0237698245.USD","LU0029874061.USD","IE00BSNM7G36.USD","HCSG","LU1261432733.SGD","XBI","IHE","IE00BJJMRZ35.SGD","LU1585245621.USD","LU0306806265.USD","IE0002141913.USD","LU0321505868.SGD","BK4534","IE00BJT1NW94.SGD","LU1868837136.USD","FTXH","LU0868494617.USD","LU1323610961.USD","LU1670711040.USD","LU1868836914.USD","LU2242646821.SGD","LU0882574055.USD","LU0225771236.USD","BK4139","BK4082","BK4548","LU0128526141.USD","LU0306807586.USD","LU1093756168.USD","NVCR","PSIL","LU1430594728.SGD","LU1291159041.SGD","LU1032466523.USD","BMY","XLV","CMPS","LU0096364046.USD","LU0267386448.USD","BK4585","LU0114720955.EUR","LU1670710661.SGD","LABU","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111408","title":"Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111408?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:40","pubTimestamp":1783946412,"startTime":"0","endTime":"0","summary":"Based on recent positive 12-week data from Part D of the CIRRUS-HCM Phase 2 trial of EDG-7500, which included safety, echocardiographic, biomarker,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-expects-to-initiate-phase-3-trial-of-edg-7500-in-q4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-expects-to-initiate-phase-3-trial-of-edg-7500-in-q4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX","BK4539","PSIL","BK4007","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115701","title":"Alkermes Price Target Announced at $60.00/share by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115701","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115701?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:10","pubTimestamp":1783941000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 07:10 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","PSCH","IBRN","ALKS","MEDX","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115250","title":"Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115250","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115250?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:01","pubTimestamp":1783940468,"startTime":"0","endTime":"0","summary":"Alkermes says alixorexton sustains wakefulness gains in nine-month narcolepsy extension study interim analysisAlkermes reported interim long-term extension results showing alixorexton sustained clinic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL7r2w61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BK4139","MEDX","PSIL","PSCH","ALKS","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651904115","title":"Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested","url":"https://stock-news.laohu8.com/highlight/detail?id=2651904115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651904115?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","IBRN","MEDX","PSCH","PSIL","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115976","title":"Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115976?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","FBT","MEDX","PSCH","ALKS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115189","title":"Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115189?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","FBT","BK4139","ALKS","MEDX","PSIL","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192046","title":"Bank of America Securities Remains a Sell on Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651192046?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:45","pubTimestamp":1783932314,"startTime":"0","endTime":"0","summary":"In a report released on July 10, Jason Gerberry from Bank of America Securities maintained a Sell rating on Alkermes, with a price target of $38.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2133065610.SGD","LU1506573853.SGD","IYF","LU0130102774.USD","FNCL","LU0130518102.USD","LU0234572021.USD","LU0868494617.USD","LU0070302665.USD","BK4207","LU0648000940.SGD","LU0648001328.SGD","LU1201861249.SGD","LU0211331839.USD","PGF","LU0320765489.SGD","LU0321505439.SGD","LU0980610538.SGD","UYG","PSIL","BAC","XLF","MEDX","IE00BZ1G4Q59.USD","ALKS","LU0203347892.USD","LU0106831901.USD","LU0417517546.SGD","LU2265009873.SGD","LU0306806265.USD","FBT","KBWB","IE00BLSP4452.SGD","LU0256863902.USD","FTXO","LU0208291251.USD","IBRN","LU1363072403.SGD","LU1718418525.SGD","VFH","IE00B19Z3581.USD","BK4581","LU1894683264.USD","IYG","LU0306807586.USD","BK4559","LU2129689514.USD","LU1894683348.USD","LU0640476718.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651193713","title":"Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2651193713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651193713?lang=en_us&edition=fundamental","pubTime":"2026-07-13 13:58","pubTimestamp":1783922324,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","IBRN","ALKS","PSIL","FBT","BK4139","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162556","title":"Noronex plans substantial multi-instrument equity raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162556","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162556?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:27","pubTimestamp":1783906060,"startTime":"0","endTime":"0","summary":"Noronex Ltd. ( ($AU:NRX) ) has issued an update. Noronex Limited has outlined plans for a new capital raising, proposing the issue of up to 196,818...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/noronex-plans-substantial-multi-instrument-equity-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/noronex-plans-substantial-multi-instrument-equity-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651169019","title":"Sabre Resources Secures $2m to Accelerate Drilling in Tennant Creek Copper-Gold Belt","url":"https://stock-news.laohu8.com/highlight/detail?id=2651169019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651169019?lang=en_us&edition=fundamental","pubTime":"2026-07-13 07:04","pubTimestamp":1783897464,"startTime":"0","endTime":"0","summary":"Sabre Resources Ltd ( ($AU:SBR) ) has shared an update. Sabre Resources has completed a A$2 million capital raising, including a second tranche of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabre-resources-secures-2m-to-accelerate-drilling-in-tennant-creek-copper-gold-belt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabre-resources-secures-2m-to-accelerate-drilling-in-tennant-creek-copper-gold-belt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4142","PSIL","BK4106","BK4588","DBB","BK4585","BK4535","SABR","AAQC","TNC","COPX","PICK","BK4161","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650159213","title":"Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650159213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650159213?lang=en_us&edition=fundamental","pubTime":"2026-07-11 22:40","pubTimestamp":1783780807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunome (IMNM) and COMPASS Pathways (CMPS) with bul...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunome-imnm-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunome-imnm-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMPS","IMNM","BK4563","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650156370","title":"Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2650156370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650156370?lang=en_us&edition=fundamental","pubTime":"2026-07-11 17:01","pubTimestamp":1783760510,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($WFC) ), ( ($BKR) ), ( ($SLB) ), ( ($HAL) ) and ( ($CMPS) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/wells-fargo-bkr-slb-hal-cmps-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/wells-fargo-bkr-slb-hal-cmps-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEZ","LU0251142724.SGD","LU1201861249.SGD","VDE","LU0130102774.USD","LU2361044949.HKD","IYF","LU1363072403.SGD","LU0267386448.USD","DIG","LU0070302665.USD","SGXZ23171101.USD","LU1261432733.SGD","LU0314106906.USD","SG9999011175.SGD","LU0251131958.USD","LU0477156953.USD","WFC","LU1069347547.HKD","LU0211327993.USD","LU0310799852.SGD","LU2461242641.AUD","SLB","LU0985489474.SGD","LU1506573853.SGD","LU1074936037.SGD","IE00B0JY6N72.USD","HAL","LU0640476718.USD","PSIL","KBWB","LU1035773651.USD","IE0002270589.USD","LU1720051108.HKD","PXJ","BKR","LU0648001328.SGD","LU1267930490.SGD","SG9999003800.SGD","CMPS","LU0072461881.USD","LU0985481810.HKD","OIH","IE00B19Z3B42.SGD","PGF","LU0154245756.USD","FTXO","LU0417517546.SGD","LU0128525689.USD","LU0011850046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650171187","title":"Mizuho Securities Remains a Buy on Relmada Therapeutics (RLMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650171187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650171187?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:55","pubTimestamp":1783684550,"startTime":"0","endTime":"0","summary":"In a report released today, Uy Ear from Mizuho Securities maintained a Buy rating on Relmada Therapeutics, with a price target of $19.00. According...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-buy-on-relmada-therapeutics-rlmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-buy-on-relmada-therapeutics-rlmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4007","RLMD","GSIB","PSIL","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650780109","title":"European Equities Traded in the US as American Depositary Receipts Rise Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2650780109","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650780109?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:10","pubTimestamp":1783609858,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Thursday morning, up 0.5% to 1,905.06 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by technology giants Nokia  and Ericsson , which gained 6% and 4.4% respectively. They were followed by semiconductor company STMicroelectronics , which climbed nearly 4%.The decliners from continental Europe were led by clinical-stage biopharmaceutical company Inventiva  and steel producer ArcelorMittal , which fell 4.3% and 1.5% respectively. They were followed by software company SAP , which shed 0.7%.From the UK and Ireland, the gainers were led by semiconductor company Arm  and bank HSBC , which climbed 12% and 2% respectively. They were followed by bank Barclays , which added 1.8%.The decliners from the UK and Ireland were led by pharmaceutical company Compass Pathways  and budget airline Ryanair , which decreased 2.2% and 1.5% respectively.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4008","LU0976567544.SGD","CMPS","BK4006","BK4561","MT","ERIC","IE00BMPRXN33.USD","BK4585","LU2543165471.USD","HSBH","BK4500","BK4141","BK4139","ARM","BK4543","LU0496365809.HKD","BK4604","00005","SAP","BCS","BK4609","BK4613","BK4566","BK4591","IVA","BK4548","IE00BMPRXR70.SGD","BK4605","BK4515","LU0266013472.USD","LU0310800965.SGD","SPRX","LU0130103400.USD","BK4521","LU0081259029.USD","ARMW","NOK","BK4547","IE00BMPRXQ63.HKD","LU0648000940.SGD","LU2236285917.USD","LU0211326755.USD","QQQA","ARMG","LU0348723411.USD","BK4532","AIPI","STM","ARMU","LU0052756011.USD","BK4023","LU1267930227.SGD","PSIL","TRFK","RYAAY","BK4020","BK4528","LU0006061336.USD","LU1232071149.USD","LU0128525689.USD","LU0211326839.USD","BK4554","LNOK","BK4207","LU1201861165.SGD","BK4588","HSBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292217","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292217?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:10","pubTimestamp":1783602606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Immunome (IMNM) with bullish sen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","IMNM","MEDX","XBI","HCSG","PSCH","IBRN","BK4137","LABU","BK4563","BK4581","BK4588","LU0128526141.USD","PSIL","ALKS","BK4139","LU0029874061.USD","FBT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}